These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12606242)

  • 21. Hypothalamic digoxin and hemispheric chemical dominance--relation to the pathogenesis of senile osteoporosis, degenerative osteoarthritis, and spondylosis.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Mar; 113(3):341-59. PubMed ID: 12803138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothalamic digoxin, cerebral dominance, and membrane biochemistry.
    Kurup RK; Kurup PA
    Int J Neurosci; 2002 Dec; 112(12):1439-47. PubMed ID: 12652896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A hypothalamic digoxin-mediated model for conscious and subliminal perception.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Jun; 113(6):815-20. PubMed ID: 12775345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schizoid neurochemical pathology-induced membrane Na(+)-K+ ATPase inhibition in relation to neurological disorders.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Dec; 113(12):1705-17. PubMed ID: 14602543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypothalamic digoxin and isoprenoid pathway dysfunction relation to alcoholic addiction, alcoholic cirrhosis, and acquired hepatocerebral degeneration--relation to hemispheric chemical dominance.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Apr; 113(4):547-63. PubMed ID: 12856482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamic Na(+)-K(+)-ATPase inhibitor characterized in two-sided liposomes containing pure renal Na(+)-K(+)-ATPase.
    Anner BM; Rey HG; Moosmayer M; Meszoely I; Haupert GT
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F144-53. PubMed ID: 2154124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothalamic digoxin, hemispheric chemical dominance, and addictive behavior.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Feb; 113(2):279-89. PubMed ID: 12751436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypothalamic digoxin related membrane Na+-K+ ATPase inhibition and familial basal ganglia calcification.
    Kurup RK; Kurup PA
    Neurosci Res; 2002 Jan; 42(1):35-44. PubMed ID: 11814607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothalamic digoxin, hemispheric chemical dominance, and spirituality.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Mar; 113(3):383-93. PubMed ID: 12803140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothalamic digoxin, regulation of neuronal transmission, and cerebral dominance.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Jun; 113(6):821-30. PubMed ID: 12775346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothalamic digoxin-mediated model for subacute sclerosing panencephalitis.
    Kurup RK; Kurup PA
    J Neurovirol; 2002 Aug; 8(4):326-34. PubMed ID: 12161817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus.
    Hallaq HA; Haupert GT
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10080-4. PubMed ID: 2557617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypothalamic digoxin, hemispheric chemical dominance, and interstitial lung disease.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Oct; 113(10):1427-43. PubMed ID: 14534040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypothalamic digoxin-mediated model for Parkinson's disease.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Apr; 113(4):515-36. PubMed ID: 12856480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disturbed hypothalamic control of Na,K-ATPase: a cause of somatic symptoms of depression.
    Rose JD
    Med Hypotheses; 1986 Feb; 19(2):179-83. PubMed ID: 2422532
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative Action of Cardiotonic Steroids on Intracellular Processes in Rat Cortical Neurons.
    Lopachev AV; Lopacheva OM; Nikiforova KA; Filimonov IS; Fedorova TN; Akkuratov EE
    Biochemistry (Mosc); 2018 Feb; 83(2):140-151. PubMed ID: 29618300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothalamic digoxin, hemispheric chemical dominance, and Alzheimer's disease.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Mar; 113(3):361-81. PubMed ID: 12803139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypothalamic digoxin, hemispheric chemical dominance, and eating behavior.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 Aug; 113(8):1127-41. PubMed ID: 12888426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypothalamic digoxin, hemispheric dominance, and neuroimmune integration.
    Kurup RK; Kurup PA
    Int J Neurosci; 2002 Apr; 112(4):441-62. PubMed ID: 12325397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothalamic digoxin, cerebral chemical dominance and myalgic encephalomyelitis.
    Kurup RK; Kurup PA
    Int J Neurosci; 2003 May; 113(5):683-701. PubMed ID: 12745627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.